Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 416 | 640 | 14,108 | 723 | 613 |
| Gross Profit | 416 | 640 | 14,108 | 723 | 613 |
| Operating Expenses | 11,409 | 11,172 | 13,900 | 15,493 | 14,614 |
| Operating Income | -10,993 | -10,532 | 208 | -14,770 | -14,001 |
| Interest Expense | 269 | 294 | 316 | 308 | 297 |
| Other Income | 286 | 12 | 953 | 260 | 2,954 |
| Pre-tax Income | -10,976 | -10,814 | 845 | -14,818 | -11,344 |
| Net Income Continuous | -10,976 | -10,814 | 845 | -14,818 | -11,344 |
| Minority Interests | 5 | N/A | -1 | -9 | -8 |
| Net Income | $-10,981 | $-10,814 | $846 | $-14,809 | $-11,336 |
| EPS Basic Total Ops | -0.19 | -0.19 | 0.02 | -0.26 | -0.20 |
| EPS Basic Continuous Ops | -0.19 | -0.19 | 0.01 | -0.26 | -0.20 |
| EPS Diluted Total Ops | -0.19 | -0.19 | 0.02 | -0.26 | -0.20 |
| EPS Diluted Continuous Ops | -0.19 | -0.19 | 0.01 | -0.26 | -0.20 |
| EBITDA(a) | $-10,857 | $-10,392 | $353 | $-14,624 | $-13,851 |